Ping Liang, PhD
Affiliations: | Stanford University, Palo Alto, CA |
Google:
"Ping Liang"Mean distance: 16.04 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorJie Zheng | grad student | UC Davis | |
Joseph C. Wu | post-doc | 2011-2014 | Stanford University Medical School (Physics Tree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Sun Y, Su J, Wang X, et al. (2023) Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome. Ebiomedicine. 95: 104741 |
Pan Z, Liang P. (2023) Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy. Handbook of Experimental Pharmacology |
Zhou J, Cui B, Wang X, et al. (2023) Overexpression of KCNJ2 enhances maturation of human-induced pluripotent stem cell-derived cardiomyocytes. Stem Cell Research & Therapy. 14: 92 |
Sun Y, Zhou J, Wang H, et al. (2022) Establishment of an induced pluripotent stem cell line (ZJULLi004-A) from a hypertrophic cardiomyopathy patient carrying MYBPC3/c.3764C>A mutation. Stem Cell Research. 64: 102898 |
He X, Song S, Yang P, et al. (2022) A rare radiotherapy-sensitive primitive neuroectodermal tumor with gene amplification in an adult: a case report and literature review. The Journal of International Medical Research. 50: 3000605221118704 |
Zhou J, Sun Y, Wang H, et al. (2022) Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation. Stem Cell Research. 64: 102883 |
Guo F, Sun Y, Wang H, et al. (2022) Generation of an induced pluripotent stem cell line from a long QT syndrome patient carrying KCNH2/1956C > A mutation. Stem Cell Research. 62: 102813 |
Qiu H, Sun Y, Pan Z, et al. (2021) Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation. Clinical and Translational Medicine. 11: e647 |
Yu M, Lei W, Cao J, et al. (2021) Requirements for human cardiomyocytes. Cell Proliferation. e13150 |
Wang X, Pan Z, Wang J, et al. (2021) Characterization of the molecular mechanisms underlying azithromycin-induced cardiotoxicity using human-induced pluripotent stem cell-derived cardiomyocytes. Clinical and Translational Medicine. 11: e549 |